Hotnews2

endpoints

endpoints 47h ago

Briggs Morrison's Crossbow unveils $77M Series B for T cell engagers

Always be in the clinic — those are the "ABCs" of biotech, drug development veteran Briggs Morrison tells Endpoints News. And that's precisely where Morrison's Crossbow Therapeutics has been for the past few quarters with its ...
endpoints 48h ago

Shanghai biotech Excalipoint gains $68.7M for T cell engagers

Over a hot pot dinner in Shanghai in the fall of 2024, former I-Mab Biopharma executives Lei Fang and Jielun Zhu began to plot their next drug development startup.
endpoints 40h ago

Sanofi, AbbVie, Novartis and AstraZeneca face revived 340B pricing case

AstraZeneca, Sanofi, AbbVie and Novartis will again face claims that they charged “unlawfully inflated prices” under the 340B drug discount program, after the case was dismissed in 2024.
endpoints 25h ago

Lantern raises $30M from Morgan Health, Echo Health Ventures

Lantern, a company that helps employers manage what they spend on specialty care, raised $30 million as its client base broadens to include work with healthcare plans.
endpoints 46h ago

FDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potential

Johnson & Johnson secured an FDA approval on Wednesday for a psoriasis pill it expects to become a megablockbuster.
endpoints 23h ago

GSK liver drug wins FDA approval

GSK’s recent deal to license out a rare liver disease drug just got sweeter.
endpoints 47h ago

Aspen's personalized Parkinson's therapy shows early promise

Aspen Neuroscience said its experimental Parkinson's disease treatment, made from a patient's own cells, showed encouraging results in a small study.
endpoints 46h ago

Ionis delays prion disease readout; Arvinas' Parkinson's biomarker data

Plus, news about Eledon, Sobi, Ovid and CytomX:
endpoints 18h ago

Verily raises $300M, sheds Alphabet’s majority control

Verily has raised $300 million in new, outside funding that ends parent company Alphabet's controlling position in the healthcare innovation company, Endpoints News has learned exclusively.
endpoints 18h ago

TerraPower’s $450M radioisotope factory; Lilly’s $126M Japan budget

TerraPower Isotopes, a subsidiary of founder Bill Gates' nuclear company TerraPower, is building an actinium-225 factory in Philadelphia. Production will start in 2029.
1 2